Universe Pharmaceuticals Net Worth
Universe Pharmaceuticals Net Worth Breakdown | UPC |
Universe Pharmaceuticals Net Worth Analysis
Universe Pharmaceuticals' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Universe Pharmaceuticals' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Universe Pharmaceuticals' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Universe Pharmaceuticals' net worth analysis. One common approach is to calculate Universe Pharmaceuticals' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Universe Pharmaceuticals' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Universe Pharmaceuticals' net worth. This approach calculates the present value of Universe Pharmaceuticals' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Universe Pharmaceuticals' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Universe Pharmaceuticals' net worth. This involves comparing Universe Pharmaceuticals' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Universe Pharmaceuticals' net worth relative to its peers.
To determine if Universe Pharmaceuticals is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Universe Pharmaceuticals' net worth research are outlined below:
| Universe Pharmaceuticals is way too risky over 90 days horizon | |
| Universe Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 32.31 M. Reported Net Loss for the year was (6.16 M) with profit before taxes, overhead, and interest of 21.89 M. | |
| About 57.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Investors in Sunflower Pharmaceutical GroupLtd have seen stellar returns of 137 percent over the past five years - Simply Wall St |
Universe Pharmaceuticals uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Universe Pharmaceuticals. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Universe Pharmaceuticals' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 9th of February 2024 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Know Universe Pharmaceuticals' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Universe Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Universe Pharmaceuticals backward and forwards among themselves. Universe Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Universe Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Acadian Asset Management Llc | 2024-03-31 | 300 | Ubs Group Ag | 2023-12-31 | 0.0 |
Follow Universe Pharmaceuticals' market capitalization trends
The company currently falls under 'Nano-Cap' category with a total capitalization of 9.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Universe Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Universe Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Project Universe Pharmaceuticals' profitablity
Universe Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Universe Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Universe Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Universe Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Universe Pharmaceuticals' profitability requires more research than a typical breakdown of Universe Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.10) | (0.1) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (0.18) | (0.17) |
When accessing Universe Pharmaceuticals' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Universe Pharmaceuticals' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Universe Pharmaceuticals' profitability and make more informed investment decisions.
The data published in Universe Pharmaceuticals' official financial statements usually reflect Universe Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Universe Pharmaceuticals. For example, before you start analyzing numbers published by Universe accountants, it's critical to develop an understanding of what Universe Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Universe Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Universe Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Universe Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Universe Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Universe Pharmaceuticals' management manipulating its earnings.
Evaluate Universe Pharmaceuticals' management efficiency
Universe Pharmaceuticals has Return on Asset of (0.0391) % which means that on every $100 spent on assets, it lost $0.0391. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1434) %, meaning that it generated no profit with money invested by stockholders. Universe Pharmaceuticals' management efficiency ratios could be used to measure how well Universe Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of June 1, 2024, Return On Tangible Assets is expected to decline to -0.13. The current year's Return On Capital Employed is expected to grow to -0.1. At present, Universe Pharmaceuticals' Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.01, whereas Total Assets are forecasted to decline to about 47.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 9.82 | 6.59 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 9.78 | 6.56 | |
| Enterprise Value Over EBITDA | (1.14) | (1.09) | |
| Price Book Value Ratio | 0.10 | 0.1 | |
| Enterprise Value Multiple | (1.14) | (1.09) | |
| Price Fair Value | 0.10 | 0.1 | |
| Enterprise Value | 0.00 | 0.00 |
The analysis of Universe Pharmaceuticals' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Universe Pharmaceuticals' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Universe Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 0.222 | Revenue 32.3 M | Quarterly Revenue Growth (0.13) | Revenue Per Share 8.913 | Return On Equity (0.14) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Universe Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Universe Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Universe Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Trippeer Richard A Jr over three weeks ago Acquisition by Trippeer Richard A Jr of 6200 shares of Universe Pharmaceuticals at 33.48 subject to Rule 16b-3 | ||
Moore Jackson W over a month ago Acquisition by Moore Jackson W of 308212 shares of Universe Pharmaceuticals at 29.22 subject to Rule 16b-3 | ||
Moore Jackson W over a month ago Acquisition by Moore Jackson W of 13100 shares of Universe Pharmaceuticals subject to Rule 16b-3 |
Universe Pharmaceuticals Corporate Filings
| 14th of May 2024 Other Reports | ViewVerify | |
| 24th of April 2024 Other Reports | ViewVerify | |
6K | 7th of February 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 30th of January 2024 Other Reports | ViewVerify |
Universe Pharmaceuticals Earnings per Share Projection vs Actual
Be your own money manager
Our tools can tell you how much better you can do entering a position in Universe Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
How to buy Universe Stock?
The net worth of Universe Pharmaceuticals is the difference between its total assets and liabilities. Universe Pharmaceuticals' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Universe Pharmaceuticals' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Universe Pharmaceuticals' net worth can be used as a measure of its financial health and stability which can help investors to decide if Universe Pharmaceuticals is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Universe Pharmaceuticals stock.Already Invested in Universe Pharmaceuticals?
The danger of trading Universe Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Universe Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Universe Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Universe Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Universe Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (1.70) | Revenue Per Share 8.913 | Quarterly Revenue Growth (0.13) | Return On Assets (0.04) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.